1. Presacral extramedullary hematopoiesis under treatment with an erythropoietin-stimulating agent for myelodysplasia

   • Tatsuya Konishi
   • Noriko Doki
   • Kazuteru Ohashi

   Images in Hematology 01 November 2018 Pages: 1 - 2

   

2. Molecular pathogenesis of leukemia and leukemic stem cells (LSCs)

   • Masahiro Kizaki

   Progress in Hematology 23 October 2018 Pages: 3 - 4

3. Oncogenic transcriptional program driven by TAL1 in T-cell acute lymphoblastic leukemia

   • Tze King Tan
   • Chujing Zhang
   • Takaomi Sanda

   Progress in Hematology 25 August 2018 Pages: 5 - 17

   

4. Metabolism as master of hematopoietic stem cell fate

   • Kyoko Ito
   • Massimo Bonora
   • Keisuke Ito

   Progress in Hematology 15 September 2018 Pages: 18 - 27

   

5. Targeting transcription factors in acute myeloid leukemia

   • Hisashi Takei
   • Susumu S. Kobayashi

   Progress in Hematology 28 June 2018 Pages: 28 - 34

   

6. What do the lineage tracing studies tell us? Consideration for hematopoietic stem cell origin, dynamics, and leukemia-initiating cells

   • Nathalia Azevedo Portilho
   • Michihiro Kobayashi
   • Momoko Yoshimoto

   Progress in Hematology 27 September 2018 Pages: 35 - 40

   

7. Comparison of efficacy and safety between intravenous ferric carboxymaltose and saccharated ferric oxide in Japanese patients with iron-deficiency anemia due to hypermenorrhea: a multi-center, randomized, open-label noninferiority study

   • Katsuya Ikuta
   • Hideki Hanashi
   • Mikio Momoeda

   Original Article 23 July 2018 Pages: 41 - 49

   

8. Safety and efficacy of intravenous ferric carboxymaltose in Japanese patients with iron-deficiency anemia caused by digestive diseases: an open-label, single-arm study

   • Katsuya Ikuta
   • Hiroaki Ito
   • Yasuo Suzuki

   Original Article 07 September 2018 Pages: 50 - 58

   

9. Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease

   • Tomoko Kimura
   • Takahiro Kuragano
   • Takeshi Nakanishi

   Original Article 19 September 2018 Pages: 59 - 69

   

10. Inhibitor development, safety, and efficacy of Advate^® in previously untreated patients with hemophilia A in a postmarketing surveillance in Japan

    • Masashi Taki
    • Katsuyuki Fukutake
    • Akira Shirahata

    Original Article 24 July 2018 Pages: 70 - 78

11. Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone

    • Junghoon Shin
    • Je-Jung Lee
    • Korean Multiple Myeloma 151 Investigators

    Original Article 05 October 2018 Pages: 79 - 90

    

12. Tumor long-axis diameter and SUVmax predict long-term responders in 90Y-ibritumomab tiuxetan monotherapy

    • Norifumi Tsukamoto
    • Akihiko Yokohama
    • Hiroshi Handa

    Original Article 10 September 2018 Pages: 91 - 97

    

13. Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation

    • Satoshi Yamasaki
    • Goichi Yoshimoto
    • For the Fukuoka Blood and Marrow Transplantation Group

    Original Article 24 September 2018 Pages: 98 - 106

    

14. A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

    • Shin-ichi Fuchida
    • Kazutaka Sunami
    • on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT)

    Original Article 04 October 2018 Pages: 107 - 114

    

15. Risk factors and survival impact of readmission after single-unit cord blood transplantation for adults

    • Yasuko Yamagishi
    • Takaaki Konuma
    • Arinobu Tojo

    Original Article 09 October 2018 Pages: 115 - 124

    

16. Massive bone marrow necrosis revealing an HIV-related primary bone marrow lymphoma: a diagnostic challenge

    • Michael D. Diamantidis
    • Vasiliki Gogou
    • Maria Papaioannou

    Case Report 06 October 2018 Pages: 125 - 129

    

17. Correction to: Systematic review of pre-clinical chronic myeloid leukaemia

    • Jew Win Kuan
    • Anselm Ting Su
    • Goro Sashida

    Correction 07 November 2018 Pages: 130 - 130

18. Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma

    • Shin-ichi Fuchida
    • Kazutaka Sunami
    • on behalf of the Japan Study Group for Cell Therapy and Transplantation (JSCT)

    Correction 07 November 2018 Pages: 131 - 131